English  |  正體中文  |  简体中文  |  總筆數 :2851816  
造訪人次 :  44958499    線上人數 :  1292
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"teng cm"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 1-25 / 190 (共8頁)
1 2 3 4 5 6 7 8 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺北醫學大學 2015 MT-4 Suppresses Resistant Ovarian Cancer Growth through Targeting Tubulin and HSP27 Pai, HC;Kumar, S;Shen, CC;Liou, JP;Pan, SL;Teng, CM
臺北醫學大學 2015 Novel oral histone deacetylase inhibitor, MPT0E028, displays potent growth-inhibitory activity against human B-cell lymphoma in vitro and in vivo Huang, HL;Peng, CY;Lai, MJ;Chen, CH;Lee, HY;Wang, JC;Liou, JP;Pan, SL;Teng, CM.
中國醫藥大學 2014-12 Novel oral histone deacetylase inhibitor, MPT0E028, displays potent growth-inhibitory activity against human B-cell lymphoma in vitro and in vivo. (Huang HL);彭婕妤(Chieh-Yu Peng);(Lai MJ);(Chen CH);(Lee HY);(Wang JC);(Liou JP)*;(Pan SL)*;(Teng CM)*
國家衛生研究院 2014-04 Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib Tsai, AC;Wang, CY;Liou, JP;Pai, HC;Hsiao, CJ;Chang, JY;Wang, JC;Teng, CM;Pan, SL
亞洲大學 2014-04 YC-1 inhibits proliferation of breast cancer cells by downregulating EZH2 expression via activation of c-Cbl and ERK Chang, LC;Chang, LC;Lin, HY;Lin, HY;Tsai, MT;Tsai, MT;鄒瑞煌;Chou, Ruey-Hwang;Lee, FY;Lee, FY;Teng, CM;Teng, CM;Hsieh, MT;Hsieh, MT;Hung, HY;Hung, HY;Huang LJ, ;余永倫;Kuo, SC;Kuo, SC;
臺北醫學大學 2014 NPRL-Z-1, as a new topoisomerase II poison, induces cell apoptosis and ROS generation in human renal carcinoma cells Wu, SY;Pan, SL;Xiao, ZY;Hsu, JL;Chen, MC;Lee, KH;Teng, CM
臺北醫學大學 2014 A novel class I HDAC inhibitor, MPT0G030, induces cell apoptosis and differentiation in human colorectal cancer cells via HDAC1/PKCδ and E-cadherin Wang, LT;Liou, JP;Li, YH;Liu, YM;Pan, SL;Teng, CM
臺北醫學大學 2014 Indolyl or Indolinyl hydroxamate compounds Chen, CS;Liou, JP;Liu, HJ;Hung, KS;Shan, PW;Chiu, WT;Teng, CM
臺北醫學大學 2014 In vitro and in vivo anti-tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells Tsai, AC;Pai, HC;Wang, CY;Liou, JP;Teng, CM;Wang, JC;Pan, SL
臺北醫學大學 2014 Indole-3-ethylsulfamoylphenylacrylamides: Potent histone deacetylase inhibitors with anti-inflammatory activity Mehndiratta, S;Hsieh, YL;Liu, YM;Wang, AW;Lee, HY;Liang, LY;Kumar, S;Teng, CM;CR*, Yang;Liou, JP*.
臺北醫學大學 2014 K20E, an oxidative-coupling compound of methyl caffeate, exhibits anti-angiogenic activities through down-regulations of VEGF and VEGF receptor-2 Lee, HY;Wang, LT;Li, YH;Pan, SL;Chen, YL;Teng, CM;Liou, JP
臺北醫學大學 2014 Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib Tsai, AC;Wang, CY;Liou, JP;Pai, HC;Hsiao, CJ;Chang, JY;Wang, JC;Teng, CM;Pan, SL.
臺北醫學大學 2014 In vitro and in vivo antitumor effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells Tsai, AC;Pai, HC;Wang, CY;Liou, JP;Teng, CM;Wang, JC;Pan, SL
國家衛生研究院 2013-08 Activated PAR-2 regulates pancreatic cancer progression through ILK/HIF-alpha–induced TGF-alpha expression and MEK/VEGF-A–mediated angiogenesis Chang, LH;Pan, SL;Lai, CY;Tsai, AC;Teng, CM
國家衛生研究院 2013-07-08 1-arylsulfonyl-5-(N-hydroxyacrylamide)indolines histone deacetylase inhibitors are potent cytokine release suppressors Lee, HY;Yang, CR;Lai, MJ;Huang, HL;Hsieh, YL;Liu, YM;Yeh, TK;Li, YH;Mehndiratta, S;Teng, CM;Liou, JP
國家衛生研究院 2013-07-08 Inside Cover: 1-arylsulfonyl-5-(N-hydroxyacrylamide)indolines histone deacetylase inhibitors are potent cytokine release suppressors(ChemBioChem 10/2013) Lee, HY;Yang, CR;Lai, MJ;Huang, HL;Hsieh, YL;Liu, YM;Yeh, TK;Li, YH;Mehndiratta, S;Teng, CM;Liou, JP
國家衛生研究院 2013-04 MPT0G066, a novel microtubule-destabilizing agent, induces cell apoptosis and potentiates antineoplastic effects of cisplatin in human ovarian cancer cells in vitro and in vivo Chen, CH;Li, YC;Chang, LH;Liou, JP;Pan, SL;Teng, CM
國家衛生研究院 2013-03 Moscatilin inhibits migration and metastasis of human breast cancer MDA-MB-231 cells through inhibition of Akt and Twist signaling pathway Pai, HC;Chang, LH;Peng, CY;Chang, YL;Chen, CC;Shen, CC;Teng, CM;Pan, SL
國家衛生研究院 2013-02 Azatyrosinamides: Novel RAS-related anticancer agents Wang, CL;Lee, O;Huang, CF;Li, EIC;Teng, CM;Pan, SL;Lian, JF;Chang, FS;Liou, JP;Wang, HP
臺北醫學大學 2013 Denbinobin induces human glioblastoma multiforme cell apoptosis through the IKKα-Akt-FKHR signaling cascade Wen, HY;Hsu, MJ;Chen, CC;Chen, BC;Hong, CY;Teng, CM;Pan, SL;Chiu, WT;Lin, CH
臺北醫學大學 2013 Azatyrosinamides: Novel Ras-related Anticancer Agents Wang, CL;On, Lee;Huang, CF;Li Eric, IC;Teng, CM;Pan, SL;Lian, JF;Chang, FS;
臺北醫學大學 2013 TW01001, a novel piperazinedione , induces mitotic arrest and autophagy in non-small cell lung cancer A549 cells Chen, MC;Chen, CH;Liu, YN;Wang, HP;Pan, SL;Teng, CM
臺北醫學大學 2013 1-Arylsulfonyl-5-(N-hydroxyacrylamide)indolines Histone Deacetylase Inhibitors Are Potent Cytokine Release Suppressors Lee, HY;Yang, CR;Lai, MJ;Huang, HL;Hsieh, YL;Liu, YM;Yeh TK.Li, YH;Mehndiratta, S;Teng, CM;JP*, Liou
國家衛生研究院 2012-09-06 Alpha-tomatine-mediated anti-cancer activity in vitro and in vivo through cell cycle- and caspase-independent pathways Chao, MW;Chen, CH;Chang, YL;Teng, CM;Pan, SL
國家衛生研究院 2012-08-22 Anticancer activity of MPT0E028, a novel potent histone deacetylase inhibitor, in human colorectal cancer HCT116 cells in vitro and in vivo Huang, HL;Lee, HY;Tsai, AC;Peng, CY;Lai, MJ;Wang, JC;Pan, SL;Teng, CM;Liou, JP

顯示項目 1-25 / 190 (共8頁)
1 2 3 4 5 6 7 8 > >>
每頁顯示[10|25|50]項目